Foghorn Therapeutics Inc (FHTX)

Dec 11, 2025

Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com

Dec 11, 2025

Dec 06, 2025

Analyst Confidence Rises for Foghorn Therapeutics Following Leadership and Pipeline Updates - Ad-hoc-news.de

Dec 06, 2025

Dec 06, 2025

Foghorn Therapeutics (NASDAQ:FHTX) Stock Rating Lowered by Wall Street Zen - Defense World

Dec 06, 2025

Dec 05, 2025

Is Foghorn Therapeutics Inc. stock attractive for hedge fundsJobs Report & AI Driven Stock Reports - Newser

Dec 05, 2025

Dec 04, 2025

Stifel Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation - Nasdaq

Dec 04, 2025

Dec 04, 2025

Stifel Initiates Coverage on FHTX with a 'Buy' Rating | FHTX Sto - GuruFocus

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics Appoints Interim CFO Jeff Sacher - TipRanks

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics Inc appoints Jeff Sacher as interim CFO - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics appoints Jeff Sacher as interim CFO and treasurer By Investing.com - Investing.com Nigeria

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics appoints Jeff Sacher as interim CFO and treasurer - Investing.com

Dec 04, 2025

Dec 04, 2025

Why Foghorn Therapeutics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Momentum Entry Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Stifel initiates Foghorn Therapeutics stock with Buy rating, $12 target By Investing.com - Investing.com South Africa

Dec 03, 2025

Dec 03, 2025

Stifel initiates Foghorn Therapeutics stock with Buy rating, $12 target - Investing.com

Dec 03, 2025

Dec 03, 2025

R/R Acute Myeloid Leukemia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Foghorn Therapeutics, AB Science, Oncoceutics, Sanofi - Barchart.com

Dec 03, 2025

Dec 03, 2025

Foghorn Therapeutics appoints interim CFO Jeff Sacher - MSN

Dec 03, 2025

Dec 02, 2025

Published on: 2025-12-02 00:54:46 - Newser

Dec 02, 2025

Dec 01, 2025

Volatility Watch: Will Foghorn Therapeutics Inc stock deliver better than expected guidanceBond Market & Verified Momentum Stock Ideas - BỘ NỘI VỤ

Dec 01, 2025

Dec 01, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Dec 01, 2025

Dec 01, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Recommendation of “Buy” from Analysts - Defense World

Dec 01, 2025

Nov 30, 2025

What analysts say about Foghorn Therapeutics Inc stockMarket Sentiment Extremes & Maximum Profit Growth - earlytimes.in

Nov 30, 2025

Nov 29, 2025

Foghorn Therapeutics (NASDAQ:FHTX) Upgraded at Wall Street Zen - MarketBeat

Nov 29, 2025

Nov 25, 2025

Foghorn Therapeutics CEO joins Evercore Healthcare Conference - Traders Union

Nov 25, 2025

Nov 25, 2025

Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times

Nov 25, 2025

Nov 25, 2025

Foghorn Therapeutics (Nasdaq: FHTX) to Join 8th Evercore Healthcare Conference - Stock Titan

Nov 25, 2025

Nov 21, 2025

Why Foghorn Therapeutics Inc. stock is a must watch in 2025Quarterly Performance Summary & Fast Moving Market Watchlists - newser.com

Nov 21, 2025

Nov 20, 2025

Can Foghorn Therapeutics Inc. stock maintain growth trajectory2025 Performance Recap & Risk Controlled Daily Plans - newser.com

Nov 20, 2025

Nov 19, 2025

How Foghorn Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Momentum & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Foghorn Therapeutics Inc. stock valuations compare to rivalsQuarterly Portfolio Report & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

Is Foghorn Therapeutics Inc. stock safe for conservative investorsQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Is Foghorn Therapeutics Inc. stock bottoming outShare Buyback & Fast Gain Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Does Foghorn Therapeutics (FHTX) Have the Potential to Rally 133.27% as Wall Street Analysts Expect? - Zacks Investment Research

Nov 19, 2025

Nov 19, 2025

FHTX: SMARCA2 program advances with Lilly partnership; multiple novel assets near IND and strong funding - TradingView

Nov 19, 2025

Nov 19, 2025

Identifying reversal signals in Foghorn Therapeutics Inc.July 2025 Action & AI Enhanced Trading Signals - newser.com

Nov 19, 2025

Nov 18, 2025

How Foghorn Therapeutics Inc. stock compares to growth peers2025 Top Gainers & Smart Investment Allocation Tips - newser.com

Nov 18, 2025

Nov 18, 2025

Check Out Foghorn Therapeutics Inc (FHTX)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 18, 2025